Virtual screening and selection of drug-like compounds to block noggin interaction with bone morphogenetic proteins
- 30 April 2010
- journal article
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 28 (7), 670-682
- https://doi.org/10.1016/j.jmgm.2010.01.006
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Fast and accurate predictions of binding free energies using MM‐PBSA and MM‐GBSAJournal of Computational Chemistry, 2009
- Potential drug targets within bone morphogenetic protein signaling pathwaysCurrent Opinion in Pharmacology, 2007
- High resolution structures of the bone morphogenetic protein type II receptor in two crystal forms: Implications for ligand bindingBiochemical and Biophysical Research Communications, 2006
- BMP and BMP Inhibitors in BoneAnnals of the New York Academy of Sciences, 2006
- Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database ScreeningJournal of Medicinal Chemistry, 2004
- Improved protein–ligand docking using GOLDProteins-Structure Function and Bioinformatics, 2003
- Structural basis of BMP signalling inhibition by the cystine knot protein NogginNature, 2002
- The Spemann Organizer Signal noggin Binds and Inactivates Bone Morphogenetic Protein 4Cell, 1996
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994
- Packing of α-helices: Geometrical constraints and contact areasJournal of Molecular Biology, 1978